| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 255 | 1.845 | 2.215 | 2.657 | 0 | 31.113 | 33.667 | 0 | 56.802 |
| Total Income - EUR | - | 255 | 1.845 | 2.215 | 2.657 | 0 | 31.113 | 33.900 | 0 | 57.141 |
| Total Expenses - EUR | - | 28 | 90 | 6 | 0 | 41 | 5.391 | 12.695 | 0 | 16.628 |
| Gross Profit/Loss - EUR | - | 227 | 1.754 | 2.209 | 2.657 | -41 | 25.722 | 21.205 | 0 | 40.513 |
| Net Profit/Loss - EUR | - | 220 | 1.683 | 2.142 | 2.540 | -41 | 24.901 | 20.208 | 0 | 33.676 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Osteoluc-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 84 | 0 | 0 | 0 | 0 | 25.971 | 21.716 | 0 | 6.460 |
| Current Assets | - | 188 | 1.986 | 4.617 | 7.132 | 6.910 | 16.211 | 32.674 | 0 | 35.840 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 203 | 0 | 10.180 |
| Cash | - | 188 | 1.986 | 4.617 | 7.132 | 6.910 | 16.211 | 2.055 | 0 | 2.541 |
| Shareholders Funds | - | 264 | 1.943 | 4.595 | 7.046 | 6.871 | 31.620 | 51.926 | 0 | 33.717 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | - | 8 | 44 | 21 | 86 | 39 | 10.561 | 2.465 | 0 | 8.583 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Osteoluc-Med Srl